| [1] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
| [2] |
Dumitrescu R, Cotarla I. Understanding breast cancer risk‐where do we stand in 2005?[J]. J Cell Mol Med, 2005, 9(1):208-21.
|
| [3] |
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors[J]. Nat Med, 2003, 9 (6):669-76.
|
| [4] |
Schneider BP, Miller KD. Angiogenesis of breast cancer[J]. J Clin Oncol, 2005, 23(8):1782-90.
|
| [5] |
Schneider BP, Sledge GW. Drug insight: VEGF as a therapeutic target for breast cancer[J]. Nat Clin Pract Oncol, 2007, 4(3):181-9.
|
| [6] |
Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk[J]. Int J Cancer, 2003, 106(4):468-71.
|
| [7] |
Jin QR, Hemminki K, Enquist K, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis[J]. Clin Cancer Res, 2005,11(10):3647-53.
|
| [8] |
Oliveira C, Loureno GJ, Silva PM, et al. Polymorphisms in the 5'-and 3'-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics[J].Tumour Biol, 2011, 32(2):295-300.
|
| [9] |
Jacobs EJ, Feigelson HS, Bain EB, et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort[J]. Breast Cancer Res, 2006, 8(2):R22.
|
| [10] |
Kataoka N, Cai Q, Wen W, et al. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(6):1148- 52.
|
| [11] |
Jakubowska A, Jaworska K, Cybulski C, et al. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? [J]. Eur J Cancer, 2009, 45(5):837-42.
|
| [12] |
Lin GT, Tseng HF, Yang CH, et al. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan[J]. OMICS, 2009, 13(2):165-72.
|
| [13] |
Balasubramanian SP, Cox A, Cross SS, et al. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity[J]. Int J Cancer, 2007, 121(5):1009-16.
|
| [14] |
Pharoah PD, Tyrer J, Dunning AM, et al. Association between common variation in 120 candidate genes and breast cancer risk[J]. PLoS Genet, 2007, 3(3):e42.
|
| [15] |
Rodrigues P, Furriol J, Tormo E, et al. The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population [J]. Breast Cancer Res Treat, 2012, 133(2):769-78.
|
| [16] |
Nakamura M, Abe Y, Tokunaga T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer[J]. Pathol Int 2002, 52(5-6):331-9.
|
| [17] |
Vincenti V, Cassano C, Rocchi M, et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3[J]. Circulation, 1996, 93(8):1493-5.
|
| [18] |
Yang B, Cross DF, Ollerenshaw M, et al. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus[J]. J Diabetes Complications, 2003, 17(1): 1-6.
|
| [19] |
Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection[J]. J Am Soc Nephrol, 2002, 13(1): 260-4.
|
| [20] |
Mohammadi M, Ollier W E R, Hutchinson IV. A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cells[J]. Human Immunology, 2003, 64: S125.
|
| [21] |
Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes[J]. Diabetes, 2002, 51(5): 1635-9.
|
| [22] |
Renner W, Kotschan S, Hoffmann C, et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels[J]. Journal of vascular research, 2000, 37(6): 443-8.
|
| [23] |
Tahara T, Shibata T, Nakamura M, et al. Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan [J]. Mol Carcinog, 2009, 48(11):1030-7.
|
| [24] |
Lin CC, Wu HC, Tsai FJ, et al. Vascular endothelial growth factor gene-460C/T polymorphism is a biomarker for prostate cancer[J]. Urology, 2003, 62(2):374-7.
|
| [25] |
Zhai R, Liu G, Asomaning K, et al. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk[J]. Carcinogenesis, 2008, 29(12):2330-4.
|
| [26] |
Ero〖AKgˇD〗lu A, ztürk A, Cam R, et al. Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients[J]. Med Oncol, 2008, 25(1):54-5.
|
| [27] |
Katalinic D, Plestina S. Vascular endothelial growth factor (VEGF) 936C/T gene polymorphism is a risk factor for invasive ductal carcinoma of the breast in a sample of Croatian woman[J]. EJC Supplements, 2009, 7（2）:149.
|
| [28] |
Gu D, Wang M. VEGF 936C> T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls[J]. Breast Cancer Res Treat, 2011, 125(2): 489-93.
|
| [29] |
Jakubowska A, Gronwald J, Menkiszak J, et al. The VEGF-936C/T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women[J]. Cancer Lett, 2008, 262(1):71-6.
|
| [30] |
Hsiao PJ, Lu MY, Chiang FY, et al. Vascular endothelial growth factor gene polymorphisms in thyroid cancer[J]. J Endocrinol, 2007, 195(2):265-70.
|
| [31] |
Hsueh C, Lin JD, Wu IC, et al. Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma[J]. J Surg Oncol, 2011, 103(5):395-9.
|
| [32] |
Dassoulas K, Gazouli M, Rizos S, et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival[J]. Mol Carcinogenesis, 2009, 48(6):563-9.
|
| [33] |
Giacalone A, Montalto G, Giannitrapani L, et al. Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma[J]. OMICS, 2011, 15(3):193-6.
|
| [34] |
Guan X, Zhao H, Niu J,et al. The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer[J]. BMC Gastroenterol, 2009, 9:77.
|
| [35] |
Ajaz S, Khaliq S, Abid A, et al. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma[J]. Genet Test Mol Biomarkers, 2011, 15(9):653-7.
|
| [36] |
Sfar S, Saad H, Mosbah F, et al. Synergistic effect and VEGF/HSP70-hom haplotype analysis: Relationship to prostate cancer risk and clinical outcome[J]. Human Immunol, 2010, 71(4):377-82.
|
| [37] |
Cao C, Fang JJ, Ying T, et al. Vascular endothelial growth factor +936C/T and +405G/C polymorphisms and cancer risk: a meta-analysis[J]. Arch Med Res, 2010, 41(7):548-57.
|
| [38] |
Xu B, Li JM, Tong N, et al. VEGFA + 936C>T polymorphism and cancer risk: a meta-analysis[J]. Cancer Genet Cytogenet, 2010, 198(1):7-14.
|
下载:
